새로운 알츠하이머병 임상진단기준

• 영문명: New Diagnostic Criteria for Alzheimer’s Disease : NIA-AA Diagnostic Guidelines
• 발행기관: 대한노인정신의학회
• 저자명: 이동영(Dong Young Lee) 손보경(Bo Kyung Sohn)
• 간행물 정보: 『노인정신의학』노인정신의학 제16권 제1호, 7~12쪽, 전체 6쪽
• 주제분류: 의약학 > 정신과학
• 파일형태: PDF
• 발행일자: 2012.06.30

영문 초록

NINCDS-ADRDA and DSM-III clinical diagnostic criteria for Alzheimer’s disease (AD) were established in early 1980s, Since then, there has been unprecedented growth of scientific knowledge and techniques including reliable biomarkers for AD pathologies as well as information about non-AD dementia, various AD phenotypes, and insufficient diagnostic accuracy of the current AD criteria, The need to test early intervention was also much elevated. All these changes recently urged to revise the current AD clinical diagnostic criteria. Against these backgrounds, the National Institute of Aging and the Alzheimer’s Association (NIA-AA)-sponsored expert workgroups proposed new diagnostic guidelines for AD in 2011, which consists of three separate parts : 1) the diagnosis of dementia due to Alzheimer’s disease ; 2) the diagnosis of mild cognitive impairment due to Alzheimer’s disease ; 3) toward defining the preclinical stage of Alzheimer’s disease. This article aimed to briefly introduce the NIA-AA guidelines and their influence on clinical researches and practice on AD.

목차

서론

본론

결론

REFERENCES

키워드

알츠하이머병 진단 가이드라인 Alzheimer disease NIA-AA Diagnosis Guideline